Key facts
- This page summarizes William E. Martin III's Form 4 filing for MARAVAI LIFESCIENCES HOLDINGS, INC. (MRVI).
- 1 reported transaction and 0 derivative rows are listed below.
- Accepted by SEC: 19 Mar 2025, 17:57.
William E. Martin III - 17 Mar 2025 Form 4 Insider Report for MARAVAI LIFESCIENCES HOLDINGS, INC. (MRVI)
- Reporting relationship
- Chief Executive Officer
- Issuer ticker
- MRVI
- Reported as of
- 17 Mar 2025
- Net transaction value
- $0
- SEC form
- 4
- Accepted by SEC
- 19 Mar 2025, 17:57:49 UTC
- Prior SEC filing
- 17 Jan 2025
- Next SEC filing
- 16 Apr 2026
- Source filing
- View source filing
- Reporting owner signature
- /s/ Kurt Oreshack, by power of attorney for William E. Martin, III
Source evidence
Original filing metadata and source links for verification.
5 source fields
Reporting owner
1 detail
Key filing fact
William E. Martin III filed Form 4 for MARAVAI LIFESCIENCES HOLDINGS, INC. (MRVI) on 19 Mar 2025.
Change
- Previous filing in this sequence was filed on 17 Jan 2025.
- Current net transaction value: $0.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
MRVI
transaction
Class A Common Stock
Award
- Transaction value
- Shares
- +986,194
- Change %
- +119%
- Price
- Shares after
- 1,814,643
- Date
- 17 Mar 2025
- Ownership
- Direct
- Footnotes
- F1
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 1 footnote
Footnote F1
Represents restricted stock units ("RSUs") awarded under the Maravai LifeSciences Holdings, Inc. 2020 Omnibus Incentive Plan. Each RSU represents the right to receive one share of Class A Common Stock of the Issuer upon vesting. The RSUs will vest in 1/3rd increments on each of March 15, 2026, March 15, 2027, and March 15, 2028, subject to the Reporting Person's continued employment with the Issuer.